Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Consolidated Statements of Cash Flows (Unaudited)

v3.21.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities    
Net loss $ (18,911) $ (21,788)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 13,802 12,457
Stock-based compensation 7,205 4,907
Foreign currency transaction loss 4,181 3,428
Deferred income taxes (1,774) (409)
Share in losses of associated companies 1,118 838
Revaluation of investments (3,670)
Other non-cash items, net 193 201
Change in cash attributable to changes in operating assets and liabilities:    
Accounts receivable, net 2,620 16,541
Inventories 7,046 (5,659)
Other current assets and prepaid expenses (3,775) 3,519
Other non-current assets 1,595 902
Accounts payable 10,197 (3,086)
Other current liabilities 6,453 9,047
Deferred revenues (433) (2,154)
Other non-current liabilities (3,096) (7,470)
Net cash provided by operating activities 22,751 11,274
Cash flows from investing activities    
Cash paid for acquisitions, net of cash acquired (6,356)
Purchase of property and equipment (4,012) (6,291)
Investments in short-term bank deposits (109,000)
Proceeds from short-term bank deposits 27,000
Net proceeds from divestitures of subsidiaries and associated companies 1,000
Purchase of intangible assets (278) (413)
Other investing activities (98) 206
Net cash used in investing activities (92,744) (5,498)
Cash flows from financing activities    
Proceeds from public offering, net of issuance costs 218,875
Proceeds from exercise of stock options 2,883 30
Other financing activities 407
Net cash provided by financing activities 222,165 30
Effect of exchange rate changes on cash, cash equivalents and restricted cash (2,872) (2,116)
Net change in cash, cash equivalents and restricted cash 149,300 3,690
Cash, cash equivalents and restricted cash, beginning of period 272,216 293,597
Cash, cash equivalents and restricted cash, end of period 421,516 297,287
Supplemental disclosures of cash flow information:    
Transfer of inventory to fixed assets 884 832
Transfer of fixed assets to inventory $ 210 $ 5